1.325
1.46%
-0.025
前日終値:
$1.35
開ける:
$1.38
24時間の取引高:
139.74K
Relative Volume:
1.15
時価総額:
$87.50M
収益:
-
当期純損益:
$-126.61M
株価収益率:
-0.637
EPS:
-2.08
ネットキャッシュフロー:
$-60.14M
1週間 パフォーマンス:
-20.82%
1か月 パフォーマンス:
-40.61%
6か月 パフォーマンス:
-60.76%
1年 パフォーマンス:
+15.68%
Generation Bio Co Stock (GBIO) Company Profile
GBIO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
GBIO | 1.325 | 87.50M | 0 | -126.61M | -60.14M | -2.08 |
VRTX | 449.93 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 746.15 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 597.50 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.03 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 108.19 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2022-11-08 | 開始されました | Canaccord Genuity | Buy |
2021-12-14 | ダウングレード | William Blair | Outperform → Mkt Perform |
2021-06-08 | 開始されました | JMP Securities | Mkt Outperform |
2021-02-24 | 開始されました | William Blair | Outperform |
2021-02-18 | 開始されました | Needham | Buy |
2020-07-07 | 開始されました | Cowen | Outperform |
2020-07-07 | 開始されました | JP Morgan | Overweight |
2020-07-07 | 開始されました | Jefferies | Buy |
2020-07-07 | 開始されました | Wedbush | Outperform |
すべてを表示
Generation Bio Co (GBIO) 最新ニュース
Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates - MSN
SK Bioscience's SKYCellflu Recognized as Next-generation World-class Product - BusinessKorea
Generation Bio's SWOT analysis: innovative gene therapy stock faces timeline hurdles - Investing.com Australia
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections - Business Wire
Next Generation Gene pioneers gene therapy approach with China data - BioWorld Online
FY2024 EPS Estimates for Generation Bio Boosted by Analyst - MarketBeat
Earnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Landlord’s alleged breach doesn’t justify end of rent payments - Massachusetts Lawyers Weekly
Generation Bio Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance UK
Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Generation Bio earnings beat by $0.04, revenue topped estimates - Investing.com
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results - The Manila Times
Generation Bio : Reports Recent Business Highlights and Third Quarter 2024 Financial Results Form 8 K - Marketscreener.com
Generation Bio Reports Breakthrough T-Cell Delivery, Slashes Q3 Losses by 46% | GBIO Stock News - StockTitan
Promising Penny Stocks On US Exchanges In November 2024 - Simply Wall St
Researchers Seek to Unlock the Secrets to Human Longevity - Securities.io
Bullish Generation Bio Insiders Loaded Up On US$778.9k Of Stock - Yahoo Finance
ST Launches AI-enhanced Bio-Sensing Chip for Next-gen Wearables - EE Times India
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 13.4% in October - MarketBeat
Layoff Tracker: Marinus Cuts Employees After Disappointing Phase III Trial - BioSpace
Generation Bio (NASDAQ:GBIO) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT - The Bakersfield Californian
Generation Bio Announces the Presentation of Preclinical - GlobeNewswire
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress - StockTitan
Cubist Systematic Strategies LLC Has $54,000 Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 6.1% in September - MarketBeat
Viral And Non-Viral Vector Manufacturing Market Report 2024-2033 | Size, Trends, Outlook - WhaTech
Alnylam’s founder brings in a $135M series A for City Therapeutics - BioWorld Online
City Therapeutics: $135 Million (Series A) Raised For RNAi-Based Medicine - Pulse 2.0
City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine - BioSpace
Renaissance Technologies LLC Sells 28,100 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio's SWOT analysis: innovative dna tech propels stock potential - Investing.com India
Generation Bio Co. (NASDAQ:GBIO) Sees Large Increase in Short Interest - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Short Interest Up 13.8% in September - Defense World
Rhumbline Advisers Buys 5,430 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Bank of New York Mellon Corp Has $527,000 Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug Collaboration - Genetic Engineering & Biotechnology News
Comparative life cycle assessment for PBAT from fossil-derived and 2nd generation biobased feedstocks - ScienceDirect.com
GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy - BioSpace
From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform - Fierce Biotech
GrowGeneration Corp [GRWG] Investment Guide: What You Need to Know - Knox Daily
Gen Digital: Strong Growth, Good Fundamentals, And Decent Price Action Make A Buy - Seeking Alpha
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? - MarketBeat
Insider Sale Alert: Gen Digital Inc [GEN] – Is it Time to sell? - Knox Daily
Cornercap Investment Counsel Inc. Sells 16,746 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (NASDAQ:GBIO) Shares Bought by Acadian Asset Management LLC - Defense World
Choreo LLC Takes $776,000 Position in Genmab A/S (NASDAQ:GMAB) - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Los Angeles Capital Management LLC - Defense World
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - ForexTV.com
Moderna falls on R&D cuts, filing delays, terminated programs - BioWorld Online
Generation Bio Co (GBIO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):